Product Introduction

PLA404 is design specially for Tonsillectomy, Adenoidectomy, CAUP, UPPP, and nasal cavity lesion tissue treatment. Tonsillary and adenoidectomy, UPPP, CAUP, and nasal cavity lesion treatment. The method and use are the same as PLA401 and PLA402. Its main feature is that the tip diameter is thinner and it will not be blocked during treatment. It has the function of cutting, ablation, hemostasis and coagulation. It is connect with PLA-700 ENT plasma surgery system to perform the operation.

Product Application

• Repeated acute attacks of chronic tonsillitis;
• A history of abscesses around the tonsils;
• Excessive hypertrophy of the tonsils, preventing swallowing or breathing, or affecting eustachian tube function;
• simple III degree hypertrophy or near III degree hypertrophy tonsils;
• Patients with rheumatic fever, nephritis, arthritis, and rheumatic heart disease who have suspected tonsils as the lesion;
• Benign tonsil tumors.

Product Advanatages

• Safety: Compared with traditional surgical methods (such as: electric knife, laser), the current does not flow through the human body, the working surface temperature is only 40 ° C to 70 ° C, and the surrounding tissue is less thermally damaged. When used in the recommended energy range, the cutting and ablation depth is controlled to ≤50μm.
• Minimally Invasive: Compared with traditional surgical methods (such as electric knife, laser), it has less heat, reduces tissue thermal damage, reduces wound healing time, reduces wound bleeding and scar formation
• High Efficiency: Compared with traditional surgical methods (such as: electric knife, laser), the patient's pain during surgery is significantly reduced, and the incidence of postoperative inflammation is significantly reduced. During the surgery, the doctor stops bleeding while cutting, and does not need other hemostasis tools.

System Set Up

DAMAI TECH CO .,LIMITED(Vayway Medical) Founded in 2008, DAMAI TECH has established itself as a leading manufacturer and supplier of innovative surgical solutions. Our portfolio encompasses a wide range of cutting-edge products, including the Plasma Surgery System, Cold Plasma Energy Platform, Coblation Plasma Surgery System, Plasma Spine Surgery Probe, Plasma ENT Surgery Probe, and Plasma Gyn Surgery Probe. Our mission is to become a comprehensive provider of surgical solutions, offering not just individual products, but entire systems that cater to the diverse needs of surgical procedures.

At the core of our offerings lie our state-of-the-art Radiofrequency (RF) Plasma Surgical Devices and Power Systems. These advanced technologies are designed to elevate the precision and efficiency of surgical interventions across various medical specialties. We strive to be the one-stop solution for all surgical needs, ensuring that healthcare professionals worldwide can access the latest in surgical innovation and excellence.

DAMAI TECH CO .,LIMITED(Vayway Medical) boasts a team of highly skilled professionals and key opinion leaders (KOLs) who are at the forefront of their fields. Their expertise and dedication have contributed significantly to our company's reputation and influence in China and beyond. Our commitment to excellence is reflected in the quality of our products, which have achieved international standards of excellence, ensuring safety, efficacy, and reliability in every surgical application.

By continuously investing in research and development, we remain at the pinnacle of surgical innovation, bringing forth products that redefine the benchmarks of surgical care. Our vision is to empower healthcare providers with tools that not only enhance patient outcomes but also streamline surgical workflows, making complex procedures simpler and more manageable.

In summary, DAMAI TECH CO .,LIMITED(Vayway Medical) stands as a testament to the fusion of cutting-edge technology, expertise, and a relentless pursuit of excellence. We are proud to be your partner in surgical innovation, committed to transforming healthcare through our comprehensive surgical solutions.